LOS ANGELES, CA -- (MARKET WIRE) -- April 25, 2007 -- Molecular Pharmacology (USA) Limited (OTCBB: MLPH) (the "Company") is pleased to announce that its progress in its drug discovery program collectively operated by its Australian subsidiary Molecular Pharmacology Limited and its principal shareholder, Pharmanet Group Limited ("MPL Group"), will be presented at the 8th World Congress on Inflammation in Copenhagen in June 2007.
